XVIVO Scientific Animation recently wrapped up an exciting project on the bacteria that are found in the human mouth and how these bacteria are affected by oral hygiene (or the lack thereof). We teamed up again with colleagues at Johnson & Johnson for a new virtual reality (VR) visualization of the normal bacterial community that …
Start-up with Style: Launch your Visuals with XVIVO
By
Michael Astrachan
As the saying goes, a picture is worth a thousand words. Start-up pharmaceutical and biotech companies often need to create illustrations, investigational candidate images, and animations to provide rich scientific detail on a disease state, a process, or a mechanism of action for their website, for presentations, and for printed materials. XVIVO Scientific Animation is …
Illustrating the Unconventional: PROTAC™ Technology for Disease Therapy
By
Michael Astrachan
XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional mechanism of action for a new class of drugs that engage the body’s own protein disposal system to target cancers and other difficult-to-treat diseases. PROTAC™ PLATFORM Arvinas’ approach is to tag a protein implicated in a disease with their proprietary Proteolysis-Targeting Chimera, …
New Year, New Reel
By
Michael Astrachan
To kick-off the New Year, we’re launching a fresh new showreel for XVIVO. 2018 was an exciting and rewarding year for the team at XVIVO Scientific Animation. We delved into new topics, such as neuroendocrine tumors and ciliary motility, we expanded our capabilities in virtual reality and interactive experiences, and we completed hundreds of projects …
Snip, Snip: New Genome Editing Tools in Development
By
Michael Astrachan
The NIH Somatic Cell Genome Editing program is supporting development of new tools and tests that may one day bring more gene therapies to patients. What if a disease could be treated by diving into a cell to edit the DNA causing the disease? That may be a reality in the not-to-distant future for many …
XVIVO and PBS Present: My Love Affair with the Brain
By
Michael Astrachan
On March 9th, your knowledge of the human brain will be challenged and revitalized through years of research and understanding conjured by the brilliant Dr.Marian Diamond. With over two million dedicated YouTube followers and a penchant for toting around a brain in a box, her special is bound to astound viewers. The PBS documentary and …
Rare Diseases Deserves a Voice
By
Michael Astrachan
Heart disease affects 1 out of every 4 people in the United States.Breast cancer affects 1 out of every 8 women in the United States.In an average year, 1 out of every 4 Americans comes down with the flu. These are recognizable conditions because they occur in many individuals. You probably know somebody who has had one of these conditions, if …
THE INNER LIFE OF THE CELL: PROTEIN PACKING
By
Michael Astrachan
Harvard University and XVIVO come together again to add to the growing series of scientific animations for BioVisions – Harvard’s multimedia lab in the department of Molecular and Cellular Biology. Protein Packing strives to more accurately depict the molecular chaos in each and every cell, with proteins jittering around in what may seem like random motion. Proteins occupy roughly …
A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
Michael Astrachan
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments. This animation takes an extensive and detailed look at the sub-populations of patients who have non-small cell lung cancer (NSCLC), which affects about 198,000 new patients in the United States each year. The animation …
GLUTAMATE MODULATION
By
Michael Astrachan
Glutamate is the most abundant excitatory neurotransmitter in the brain. Release of glutamate is essential for normal function of neurons, but the levels of this neurotransmitter must be tightly regulated to avoid toxic effects on neurons. XVIVO partnered with Biohaven to animate the glutamate story. The script details normal glutamate signaling, dysfunctional glutamate signaling and …